Key result
Reversible heart failure can be caused by toxic effects from prescribed and illicit drugs, as well as tachycardiomyopathy, driven by mitochondrial and calcium processing abnormalities.
Reversible heart failure can be driven by toxic effects from drugs or tachycardiomyopathy, primarily through mechanisms involving mitochondrial dysfunction and abnormal myocytic calcium processing.
Answers are grounded in this paper and cite their sources.
Prompts consideration of reversible etiologies in new HF; leaves open prospective validation of targeted therapies.
Heart failure is usually a relentless condition associated with a poor prognosis. Triggered by a physiological insult, maladaptive neurohumoral processes result in an ever-spiralling deterioration of cardiovascular function. However, there are certain underlying conditions which are associated with a temporary reduction in contractile function leading to reversible heart failure. These conditions affect a relatively small number of patients when compared with heart failure secondary to inherited cardiomyopathies and ischaemic heart disease. There are two broad mechanisms responsible for reversible myocyte dysfunction: acute inflammatory activation in which cytokines depress myocyte function, and toxic effects in which there is impairment of intra-cellular energetics. In this review, we discuss reversible heart failure caused by toxic effects. These effects can be caused by drugs (prescribed and illicit) and by tachycardic arrhythmia (tachycardiomyopathy), and are caused by abnormalities of mitochondrial function and myocytic calcium processing. The underlying pathological mechanisms, clinical features and management options are discussed, illustrated by clinical case studies.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2012) conducted a review in Reversible heart failure. Toxic effects (drugs and tachycardiomyopathy) was evaluated. Reversible heart failure can be caused by toxic effects from prescribed and illicit drugs, as well as tachycardiomyopathy, driven by mitochondrial and calcium processing abnormalities.
Synapse has enriched 10 related papers. Consider them for comparative context: